Correction to: Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain

Correction to: CNS Drugs (2018) 32:849–861 10.1007/s40263-018-0554-0

Page 856: Fig. 6 was an incorrect duplication of Fig. 5. The correct figure (Fig. 6) is given below.

Fig. 6.

Ion-mobility spectrometry–mass spectrometry drift time as a function of mass/charge (m/z) after 24 h of incubation shows the profile of Aβ42 oligomers with 1000-fold excess of 3-sulfopropanoic acid